The DOI matches its Crossref record.
X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060)
Abstract
X‐linked cardioskeletal myopathy, neutropenia and abnormal mitochondria (MIM 302060) (synonyms: Barth syndrome, 3‐methylglutaconic aciduria type II, endocardial fibroelastosis type 2) has been reported in patients and families from Europe, North America and Australia. Previous studies characterized the main components of the disease: dilated cardiomyopathy, skeletal myopathy, neutropenia, 3‐methylglutaconic aciduria and diminished statural growth. Respiratory chain impairments have been found in several studies, without pinpointing a single enzyme complex. 3‐Methylglutaconic aciduria is shared with several other disorders that affect the respiratory chain. Previous studies excluded a block in the major pathway of leucine catabolism. We performed leucine loading, accompanied by fasting, in patients and observed a significant rise of 3‐methylglutaconic acid and 3‐methylglutaric acid. Taken together with the absence of an enzymatic block in the major leucine catabolic route, the possibility remains that the increased basal excretion of 3‐methylglutaconic acid and other products of branched‐chain amino acids is the result of overload of this pathway or — more likely — mitochondrial leakage. Linkage studies have localized the gene to the Xq28 region. The associated tafazzin gene (TAZ), has been fully characterized recently, and mutations located in conserved regions have been reported. Carrier detection and prenatal diagnosis have now become possible through mutation analysis. Sequence homology of the TAZ gene to a highly conserved superclass of acyltransferases (Neuwald's hypothesis) predicts a glycerophospholipid as the missing end product. This points to the (lipid) structure of the inner mitochondrial membrane as a promising new area of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mitochondrial Cristae: Where Beauty Meets Functionality
Cogliati, S., Enriquez, J. A., & Scorrano, L. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.001 · Cited by 816
The Enzymatic Function of Tafazzin
Xu, Y., Malhotra, A., Ren, M., & Schlame, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606100200 · Cited by 327
X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update
Barth, P. G., Valianpour, F., Bowen, V. M., Lam, J., Duran, M., Vaz, F. M., & Wanders, R. J. A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20660 · Cited by 283
Self-citationDeficiency of tetralinoleoyl‐cardiolipin in Barth syndrome
Schlame, M., Towbin, J. A., Heerdt, P. M., Jehle, R., DiMauro, S., & Blanck, T. J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10176 · Cited by 279
Molecular symmetry in mitochondrial cardiolipins
Schlame, M., Ren, M., Xu, Y., Greenberg, M. L., & Haller, I. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.08.002 · Cited by 278
Metadata
- Authors
- Barth, P. G., Wanders, R. J. A., Vreken, P., Janssen, E. A. M., Lam, J., & Baas, F.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 22
- Issue
- 4
- Pages
- 555-567
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1600980171
- Cited by
- 170
- References
- 0
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). https://app.cochat.ai/papers/10.1023/a:1005568609936
- The paper
- Barth, P. G., Wanders, R. J. A., Vreken, P., Janssen, E. A. M., Lam, J., & Baas, F. (1999). X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). Journal of Inherited Metabolic Disease. https://doi.org/10.1023/a%3A1005568609936
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.